Logo (Actavis) 855 Pill - yellow oval, 12mm
Pill with imprint Logo (Actavis) 855 is Yellow, Oval and has been identified as Guanfacine Hydrochloride Extended-Release 4 mg. It is supplied by Actavis Pharma, Inc.
Guanfacine is used in the treatment of ADHD; High Blood Pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 855
Guanfacine Hydrochloride Extended-Release
- Imprint
- Logo (Actavis) 855
- Strength
- 4 mg
- Color
- Yellow
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
fumaric acid,
hypromelloses,
lactose monohydrate,
microcrystalline cellulose,
povidone,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-2855 | Actavis Pharma, Inc. |
| 42291-0327 | AvKare, Inc. |
More about guanfacine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (313)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antiadrenergic agents, centrally acting
- Breastfeeding
- En español
Patient resources
- Guanfacine drug information
- Guanfacine (Advanced Reading)
- Guanfacine Extended-Release Tablets
- Guanfacine Tablets
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
